Drug Chatter -- Tracking biopharma stock chatter

Profile for VBI Vaccines Inc. (VBIV)

« Back to company index

VBIV Chatter Timeline

Stock Ticker for VBIV

Most Active Tweeters for VBIV

UserTweets
@OlympiaReport 3
@TranscriptDaily 3
@WeekHerald 2
@AmericanBanking 2
@ZolmaxNews 2

Recent Tweets for VBIV

StockTexts @StockTexts
$VBIV Well Leveraged: VBI Vaccines Outlines Clinical Trial Progress https://t.co/YwvESjhwQ2
May 22nd 2018, 1:05pm
ConsumerFeed @ConsumerFeed
Insider Buying: VBI Vaccines $VBIV Insider Purchases $30,500.00 in Stock https://t.co/NgbcLbWBGG
May 17th 2018, 5:05pm
WeekHerald @WeekHerald
Insider Buying: VBI Vaccines $VBIV Insider Purchases $30,500.00 in Stock https://t.co/dCL2blsOhO
May 17th 2018, 10:05am
dailypoliticaln @dailypoliticaln
VBI Vaccines $VBIV Receives $10.50 Average Price Target from Brokerages https://t.co/ScKDQzrZPS
May 16th 2018, 7:05pm
ledgerzette @ledgerzette
VBI Vaccines $VBIV Receives $10.50 Average Price Target from Brokerages https://t.co/dSkmuFZ0Nd
May 16th 2018, 7:05pm
UHDTrader @UHDTrader
$VBIV - Now at $3.54 and going!!! https://t.co/KUZGeqYOYU
May 16th 2018, 1:05pm
SpartanTrading @SpartanTrading
$TCMD flagging here $VBIV confirming the 50 break on daily for now
May 16th 2018, 1:05pm
TranscriptDaily @TranscriptDaily
Insider Buying: VBI Vaccines $VBIV Insider Buys 10,000 Shares of Stock https://t.co/7AakigyxQ2
May 16th 2018, 10:05am
TranscriptDaily @TranscriptDaily
Jeff Baxter Acquires 7,100 Shares of VBI Vaccines $VBIV Stock https://t.co/Jkd5siIeyp
May 16th 2018, 10:05am
UHDTrader @UHDTrader
$VBIV - 12-month price target for the shares is US$9.3!!!! VBI Vaccines Announces Positive Final Phase 1 Study Resu… https://t.co/ZfkczOkzlw
May 15th 2018, 2:05pm
VBIVaccines @VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine featured in… https://t.co/XOjRxiUTP7
May 15th 2018, 12:05pm
carver1009 @carver1009
Interesting set up for $VBIV price action. https://t.co/qXp1WZTdI4
May 15th 2018, 12:05pm
ZolmaxNews @ZolmaxNews
VBI Vaccines $VBIV CEO Jeff Baxter Purchases 7,100 Shares of Stock https://t.co/rS1ymYhuEw
May 15th 2018, 9:05am
TheMarketsDaily @TheMarketsDaily
Insider Buying: VBI Vaccines $VBIV CEO Purchases 7,100 Shares of Stock https://t.co/AyJgaGxF7J
May 15th 2018, 9:05am
OlympiaReport @OlympiaReport
Insider Buying: VBI Vaccines $VBIV Insider Acquires 10,000 Shares of Stock https://t.co/AvvIZZRs2S
May 15th 2018, 9:05am
ThisLincolnian @ThisLincolnian
VBI Vaccines $VBIV CEO Jeff Baxter Buys 7,100 Shares https://t.co/nNQR8EDlth
May 14th 2018, 9:05pm
dakotafinancial @dakotafinancial
Jeff Baxter Buys 7,100 Shares of VBI Vaccines $VBIV Stock https://t.co/EsPzSm4K4i
May 14th 2018, 8:05pm
AmericanBanking @AmericanBanking
VBI Vaccines $VBIV CEO Jeff Baxter Buys 7,100 Shares https://t.co/wNiXgkVnsw #stocks
May 14th 2018, 8:05pm
AmericanBanking @AmericanBanking
Insider Buying: VBI Vaccines $VBIV Insider Purchases 10,000 Shares of Stock https://t.co/B5TWMaNgQQ #stocks
May 14th 2018, 8:05pm
SleekMoneycom @SleekMoneycom
Insider Buying: VBI Vaccines $VBIV Insider Purchases 10,000 Shares of Stock https://t.co/T1nycjCRH5 #investing
May 14th 2018, 8:05pm
insiderbuyings @insiderbuyings
$VBIV new insider buying: 10000 shares. https://t.co/SBo2zBlsUC
May 14th 2018, 5:05pm
TranscriptDaily @TranscriptDaily
Somewhat Positive Press Coverage Somewhat Unlikely to Impact VBI Vaccines $VBIV Share Price https://t.co/BFzvsQo2Mc
May 13th 2018, 3:05pm
OlympiaReport @OlympiaReport
BMO Capital Markets Raises VBI Vaccines $VBIV Price Target to $13.00 https://t.co/vOLD5i2PUW
May 13th 2018, 12:05pm
WeekHerald @WeekHerald
VBI Vaccines $VBIV Sees Large Volume Increase After Analyst Upgrade https://t.co/udHWBtNX6L
May 12th 2018, 7:05pm
OlympiaReport @OlympiaReport
VBI Vaccines $VBIV Sees Large Volume Increase After Analyst Upgrade https://t.co/f5tWqouliD
May 12th 2018, 6:05pm
ThisLincolnian @ThisLincolnian
VBI Vaccines $VBIV Sees Large Volume Increase on Analyst Upgrade https://t.co/6PICpoEHTH
May 12th 2018, 6:05pm
WatchlistN @WatchlistN
VBI Vaccines $VBIV Price Target Increased to $13.00 by Analysts at BMO Capital Markets https://t.co/2giaFOjXrh
May 12th 2018, 1:05pm
StockNewsNow @StockNewsNow
$VBIV VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine https://t.co/z070x8kTqP
May 10th 2018, 12:05pm
ZolmaxNews @ZolmaxNews
VBI Vaccines $VBIV Earns Outperform Rating from BMO Capital Markets https://t.co/XuL4eH66BD
May 10th 2018, 11:05am
dailypoliticaln @dailypoliticaln
VBI Vaccines $VBIV Earns Outperform Rating from BMO Capital Markets https://t.co/3WxhMXsNWb
May 10th 2018, 11:05am
nyaj95 @nyaj95
$vbiv Extremely bullish on the CMV vaccine. CMV infection is a major problem in case you didn't know. Can cause ser… https://t.co/q6PSI5Fb13
May 10th 2018, 11:05am
MarketCurrents @MarketCurrents
VBI's CMV vaccine candidate shows positive effect in early-stage study; shares ahead 11% premarket https://t.co/PikPeYUmG0 #premarket $VBIV
May 10th 2018, 8:05am
scalp2trade @scalp2trade
$VBIV Worth putting up on the Board. VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative… https://t.co/FMdKOwmEN7
May 10th 2018, 8:05am
JUSTUSnatuhwera @JUSTUSnatuhwera
RT @OpenOutcrier: $VBIV (+3.1% pre) VBI Vaccines Announces Positive Final Ph 1 Study Results Of Preventative CMV Vaccine - Reuters https:/…
May 10th 2018, 8:05am
OpenOutcrier @OpenOutcrier
$VBIV (+3.1% pre) VBI Vaccines Announces Positive Final Ph 1 Study Results Of Preventative CMV Vaccine - Reuters https://t.co/RAnQmtu05g
May 10th 2018, 8:05am
CRWECrownEquity @CRWECrownEquity
$VBIV Reveals findings from early-stage study testing its prophylactic cytomegalovirus vaccine candidate VBI-1501 https://t.co/9VgDujOIl6
May 10th 2018, 7:05am
Ultra_Calls @Ultra_Calls
$VBIV VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine
May 10th 2018, 7:05am
stockelite @stockelite
$VBIV VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine https://t.co/M1kfofjA23
May 10th 2018, 7:05am
GNWLive @GNWLive
VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine $VBIV https://t.co/P8aRnF3P1a
May 10th 2018, 7:05am
MrZackMorris @MrZackMorris
$VBIV VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine
May 10th 2018, 7:05am
odibro @odibro
$VBIV Announces Positive Phase 1 Study Results of Preventative CMV Vaccine https://t.co/hRxN5MnUR5
May 10th 2018, 7:05am
StockflareUS @StockflareUS
$VBIV: Forecast sales for VBI Vaccines Inc are no longer forecast to rise this year. (https://t.co/Z6ZpqSRJaZ)
May 9th 2018, 6:05am
dakotafinancial @dakotafinancial
VBI Vaccines $VBIV Receives Consensus Recommendation of “Hold” from Analysts https://t.co/w2eGpqgefc
May 9th 2018, 3:05am
dispatchtribune @dispatchtribune
VBI Vaccines $VBIV Reaches New 12-Month High and Low at $2.91 https://t.co/GqzcvTdu0o
May 8th 2018, 8:05pm
OlympiaReport @OlympiaReport
VBI Vaccines $VBIV Hits New 12-Month High and Low at $2.91 https://t.co/qNzWFnSyfL
May 8th 2018, 8:05pm
ThisLincolnian @ThisLincolnian
VBI Vaccines $VBIV Reaches New 12-Month High and Low at $2.91 https://t.co/Nn9oOKujTo
May 8th 2018, 8:05pm
TheMarketsDaily @TheMarketsDaily
Somewhat Positive Media Coverage Somewhat Unlikely to Impact VBI Vaccines $VBIV Share Price https://t.co/zWgLJkYJBT
May 8th 2018, 2:05pm
ledgerzette @ledgerzette
Somewhat Positive Media Coverage Somewhat Unlikely to Impact VBI Vaccines $VBIV Share Price https://t.co/JNhCwIKpXv
May 8th 2018, 2:05pm
iTwitsTrade @iTwitsTrade
$VBIV another low float stock that keeps pushing up as it bounce of its lows again support @3 https://t.co/fGA2wmS0fe
May 7th 2018, 12:05pm
ConsumerFeed @ConsumerFeed
VBI Vaccines $VBIV Upgraded to “Hold” at ValuEngine https://t.co/zvM8fLQjtx
May 6th 2018, 9:05pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.